MATERNAL SERUM SCREEN 2 ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA MBFD CHROMOSOME 21 Test
Welcome to DNA Labs UAE, where we offer the Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test. This prenatal screening test helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21.
Test Components
- PAPP-A
- Free Beta HCG
- Risk Evaluation
- MBFD-21
Price
800.0 AED
Sample Condition
3 mL (1.5 mL min.) serum from 1 SST. Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Ship refrigerated or frozen. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along with duly filled Maternal Serum Screen 2 reflex to MBFD-21 consent form (Form 12). Ship refrigerated. DO NOT FREEZE. Valid between 10-13 weeks gestation.
Report Delivery
Dual test: Sample Mon through Sat by 9 am; Report Same day
MBFD-21: Sample Tue by 9 am; Report Next Tue
Method
Chemiluminescent Immunoassay, DNA Sequencing
Test Type
Prenatal Diagnosis
Doctor
Gynecologist
Test Department
Pre Test Information
Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along with duly filled Maternal Serum Screen 2 reflex to MBFD-21 consent form (Form 12). Valid between 10-13 weeks gestation.
Test Details
The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test is a prenatal screening test that helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21. During pregnancy, a small amount of fetal DNA can be found in the mother’s bloodstream. This test utilizes advanced technology to analyze the maternal blood sample and specifically detect any abnormalities in Chromosome 21, such as Down syndrome (Trisomy 21).
The test is typically recommended for pregnant women who have an increased risk of having a baby with chromosomal abnormalities, based on factors like maternal age, family history, or previous abnormal test results. It can also be offered as a follow-up test if an initial screening test suggests a higher risk.
The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test provides a more accurate assessment of the risk compared to traditional screening methods. However, it is important to note that this test is not diagnostic and cannot provide a definitive diagnosis of a chromosomal abnormality. If the test results indicate an increased risk, further diagnostic testing, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the findings.
It is essential to discuss the benefits, limitations, and potential risks of this test with a healthcare provider to make an informed decision about whether to proceed with the Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test.
| Test Name | MATERNAL SERUM SCREEN 2 ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA MBFD CHROMOSOME 21 Test |
|---|---|
| Components | *PAPP-A*Free Beta HCG*Risk Evaluation *MBFD-21 |
| Price | 800.0 AED |
| Sample Condition | 3 mL (1.5 mL min.) serum from 1 SST. Provide maternal Date of birth (dd\/mm\/yy); LMP or Ultrasound; Number of Fetuses (Single\/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Ship refrigerated or frozen. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21\/NIPT along withduly filled Maternal Serum Screen 2 reflex to MBFD-21 consentform (Form 12). Ship refrigerated. DO NOT FREEZE. Valid between 10-13 weeks gestation. |
| Report Delivery | Dual test: Sample Mon through Sat by 9 am; Report Same dayMBFD-21: Sample Tue by 9 am; Report Next Tue |
| Method | Chemiluminescent Immunoassay,DNA Sequencing |
| Test type | Prenatal Diagnosis |
| Doctor | Gynecologist |
| Test Department: | |
| Pre Test Information | Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy.All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along withduly filled Maternal Serum Screen 2 reflex to MBFD-21 consentform (Form 12). Valid between 10-13 weeks gestation. |
| Test Details | The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test is a prenatal screening test that helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21. During pregnancy, a small amount of fetal DNA can be found in the mother’s bloodstream. This test utilizes advanced technology to analyze the maternal blood sample and specifically detect any abnormalities in Chromosome 21, such as Down syndrome (Trisomy 21). The test is typically recommended for pregnant women who have an increased risk of having a baby with chromosomal abnormalities, based on factors like maternal age, family history, or previous abnormal test results. It can also be offered as a follow-up test if an initial screening test suggests a higher risk. The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test provides a more accurate assessment of the risk compared to traditional screening methods. However, it is important to note that this test is not diagnostic and cannot provide a definitive diagnosis of a chromosomal abnormality. If the test results indicate an increased risk, further diagnostic testing, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the findings. It is essential to discuss the benefits, limitations, and potential risks of this test with a healthcare provider to make an informed decision about whether to proceed with the Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test. |
